Connect your AI

Biote Corp. BTMD Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

TargetTGT

——

Walmart WMT

——

Lifecore Biomedical, Inc.LFCR

——

BioLife SolutionsBLFS

——

NAG

Niagen Bioscience, Inc. Common StockNAGE

——

Lifevantage CorporationLFVN

——

Other financials

Income statement

Revenue$44.9M-8.3%

Gross profit$31.0M-14.9%

Operating income$3.2M-67.3%

Net income$2.3M-83.4%

EPS (diluted)$0.06-83.8%

Balance sheet

Cash & equivalents$5.3M-87.2%

Total debt$103.4M-5.5%

Total equity-$56.1M+37.7%

Total assets$89.0M-27.8%

Cash flow

Operating cash flow$3.9M-39.7%

CapEx$362.0K-77.8%

Free cash flow$3.5M-26.8%

Valuation

Market cap$57.33M-51.2%

Enterprise value$155.43M-26.5%

P/E3.7×-0.1×

P/S0.3×-0.3×

Profitability

Gross margin70.1%-1.2pp

Operating margin15.4%-0.1pp

Net margin8.3%-2.3pp

FCF margin15.3%-3.2pp

Returns & leverage

Return on equity-21.4%—

Debt / equity9.1×—

Current ratio1.3×-0.1×

Where this comes from

Reported directly by Biote Corp. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Biote Corp.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biote Corp.'s deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Biote Corp.'s deferred tax assets and other non-current assets?: Biote Corp. (BTMD) reported deferred tax assets and other non-current assets of $72K in Q1 2026.
How has Biote Corp.'s deferred tax assets and other non-current assets changed year-over-year?: Biote Corp.'s deferred tax assets and other non-current assets decreased by 0.0% year-over-year, from $72K to $72K.